Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Express Scripts
US Department of Justice
Colorcon
UBS
Daiichi Sankyo
Cerilliant
Julphar

Generated: August 18, 2018

DrugPatentWatch Database Preview

Jazz Pharms Intl Company Profile

« Back to Dashboard

What is the competitive landscape for JAZZ PHARMS INTL, and when can generic versions of JAZZ PHARMS INTL drugs launch?

JAZZ PHARMS INTL has one approved drug.

There are three US patents protecting JAZZ PHARMS INTL drugs.

There are six patent family members on JAZZ PHARMS INTL drugs in four countries and two supplementary protection certificates in two countries.

Summary for Jazz Pharms Intl
International Patents:6
US Patents:3
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Jazz Pharms Intl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-001 Dec 28, 2004 RX Yes Yes 8,653,033 ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-002 Dec 28, 2004 RX Yes Yes 9,707,270 ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-001 Dec 28, 2004 RX Yes Yes 8,765,680 ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-003 Dec 28, 2004 DISCN No No 8,653,033 ➤ Sign Up ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-001 Dec 28, 2004 RX Yes Yes 9,707,270 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Jazz Pharms Intl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-001 Dec 28, 2004 5,795,864 ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-004 Dec 28, 2004 5,795,864 ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-002 Dec 28, 2004 5,364,842 ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-004 Dec 28, 2004 5,364,842 ➤ Sign Up
Jazz Pharms Intl PRIALT ziconotide acetate INJECTABLE;INTRATHECAL 021060-002 Dec 28, 2004 5,859,186 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Jazz Pharms Intl

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,268,774 Method for reducing pain ➤ Sign Up
7,268,109 Method for reducing pain ➤ Sign Up
8,513,198 Pharmaceutical formulation for reducing pain ➤ Sign Up
7,833,973 Pharmaceutical formulations for reducing pain ➤ Sign Up
7,524,812 Pharmaceutical formulation comprising ziconotide ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Jazz Pharms Intl Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0027 France ➤ Sign Up PRODUCT NAME: ZICONOTIDE; REGISTRATION NO/DATE IN FRANCE: EU/1/04/302/001 DU 20050221; REGISTRATION NO/DATE AT EEC: EU/1/04/302/001-003 DU 20050221
C/GB05/033 United Kingdom ➤ Sign Up PRODUCT NAME: ZICONOTIDE, OPTIONALLY IN THE FORM OF A SALT WITH A PHARMACEUTICALLY ACCEPTABLE ACID, INCLUDING ZICONOTIDE ACETATE; REGISTRATION NO/DATE: EU/1/04/302/001 - 003 20050224
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Colorcon
Chubb
Citi
Argus Health
Merck
US Army
Deloitte
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.